Antibodies could improve cancer screenings

Researchers in Oregon have developed antibodies that can recognize pancreatic cancer, reports claim.

Cancer cells in pancreatic tissues involved in the transport of enzymes out of the pancreas are recognized by the new antibodies, a development which could lead to earlier detection and treatment.

"The next step is to use these antibodies in a sensitive screening test to determine their full potential in diagnosis of this devastating disease," said pancreatic cancer surgeon Dr Brett Sheppard.

Doctors at the Oregon Health & Science University have injected pancreas cells into mice that secrete antibodies which can be screened for their reaction with normal pancreatic and pancreatic cancer tissues.

"We hope that the new antibodies introduced in San Diego will allow early detection and treatment of pancreatic cancer," said Dr Philip Streeter.

Due to lack of screening and low levels of detection rates, pancreatic cancer is the fourth-leading cause of cancer death in the United States.